SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer.
暂无分享,去创建一个
M. Rubin | D. Rickman | F. Demichelis | R. Kuefer | A. De la taille | S. Setlur | D. Pflueger | Benjamin J. Moss | Ashutosh K. Tewari | V. E. VanDoren | Chen X. Chen
[1] Lee T. Sam,et al. Transcriptome Sequencing to Detect Gene Fusions in Cancer , 2009, Nature.
[2] Joshua M. Korn,et al. Integrated detection and population-genetic analysis of SNPs and copy number variation , 2008, Nature Genetics.
[3] S. Dhanasekaran,et al. A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer. , 2008, Cancer research.
[4] K. Waltering,et al. Identification of ETS-like transcription factor 4 as a novel androgen receptor target in prostate cancer cells , 2008, Oncogene.
[5] John T. Wei,et al. The role of SPINK1 in ETS rearrangement-negative prostate cancers. , 2008, Cancer cell.
[6] T. Golub,et al. Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer. , 2008, Journal of the National Cancer Institute.
[7] Jianjun Yu,et al. A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer. , 2008, Cancer research.
[8] J Cuzick,et al. Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer , 2008, Oncogene.
[9] J. Witjes,et al. Detection of TMPRSS2-ERG Fusion Transcripts and Prostate Cancer Antigen 3 in Urinary Sediments May Improve Diagnosis of Prostate Cancer , 2007, Clinical Cancer Research.
[10] S. Dhanasekaran,et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer , 2007, Nature.
[11] Y Pawitan,et al. TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort , 2007, Oncogene.
[12] M. Rubin,et al. Morphological features of TMPRSS2–ERG gene fusion prostate cancer , 2007, The Journal of pathology.
[13] J. Tchinda,et al. TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. , 2006, Cancer research.
[14] J. Tchinda,et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. , 2006, Science.
[15] R. Sorek,et al. Transcription-mediated gene fusion in the human genome. , 2005, Genome research.
[16] Tom Maniatis,et al. Delay in synthesis of the 3' splice site promotes trans-splicing of the preceding 5' splice site. , 2005, Molecular cell.
[17] Yidong Chen,et al. High-resolution analysis of gene copy number alterations in human prostate cancer using CGH on cDNA microarrays: impact of copy number on gene expression. , 2004, Neoplasia.
[18] M. López‐Fraga,et al. An endogenous hybrid mRNA encodes TWE‐PRIL, a functional cell surface TWEAK–APRIL fusion protein , 2002, The EMBO journal.
[19] S. Varambally,et al. Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer. , 2008, Cancer research.